H-group (homology)
220.1 PH domain-like
Ligands and drugs
10,352
Member domains
514
with ligand contacts (≤ 4 Å)
5.0% of members
470
with DrugDomain annotations
4.5% of members
350
with a DrugBank compound
3.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 220.1 belongs to X-group 220 PH domain-like, which binds 7.7 ligand superclasses per 20 proteins, broader than 51% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01863 | 4IP | Inositol 1,3,4,5-Tetrakisphosphate | 29 |
| DB03401 | I3P | 1D-myo-inositol 1,4,5-trisphosphate | 11 |
| DB12010 | — | Fostamatinib | 5 |
| DB00120 | PHE | Phenylalanine | 4 |
| DB02082 | GNP | Phosphoaminophosphonic acid guanylate ester | 4 |
| DB14981 | IHP | Phytic acid | 4 |
| DB02175 | MLA | Malonic acid | 3 |
| DB03344 | I5P | Inositol-(1,3,4,5,6)-Pentakisphosphate | 3 |
| DB04522 | SEP | Dexfosfoserine | 3 |
| DB02676 | B3P | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | 2 |
| DB03345 | BME | Mercaptoethanol | 2 |
| DB15035 | — | — | 2 |
| DB00122 | — | Choline | 1 |
| DB00133 | SER | Serine | 1 |
| DB00142 | GLU | Glutamic acid | 1 |
| DB00144 | — | Phosphatidyl serine | 1 |
| DB00482 | — | Celecoxib | 1 |
| DB00619 | — | Imatinib | 1 |
| DB00630 | — | Alendronic acid | 1 |
| DB00697 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 45 |
| ZNmetal | ZINC ION | 40 |
| 4IP | INOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE | 33 |
| CL | CHLORIDE ION | 26 |
| UNX | UNKNOWN ATOM OR ION | 17 |
| I3P | D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE | 9 |
| BR | BROMIDE ION | 8 |
| 4PT | (2R)-3-{[(S)-{[(2S,3R,5S,6S)-2,6-DIHYDROXY-3,4,5-TRIS(PHOSPHONOOXY)CYCLOHEXYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-(1-HYDROXYBUTOXY)PROPYL BUTYRATE | 6 |
| CSmetal | CESIUM ION | 5 |
| NAmetal | SODIUM ION | 5 |
| 8SE | (3~{S},7~{R},10~{R},13~{S})-4-[[(3~{S},7~{R},10~{R},13~{S})-4-[(2~{S})-2-acetamido-3-(2-chlorophenyl)propanoyl]-2-oxidanylidene-1,4-diazatricyclo[8.3.0.0^{3,7}]tridec-8-en-13-yl]carbonyl]-2-oxidanylidene-1,4-diazatricyclo[8.3.0.0^{3,7}]tridec-8-ene-13-carboxylic acid | 4 |
| A1JIA | (6~{S})-6-(5-bromanylthiophen-2-yl)-6,7-dihydro-1-benzofuran-3-carboxylic acid | 4 |
| CAmetal | CALCIUM ION | 4 |
| IHP | INOSITOL HEXAKISPHOSPHATE | 4 |
| NImetal | NICKEL (II) ION | 4 |
| NXT | 4,5,6,7-tetrahydro-1-benzofuran-3-carboxylic acid | 4 |
| NYQ | 5-bromanyl-1,3-dihydroindol-2-one | 4 |
| PHE | PHENYLALANINE | 4 |
| SEP | PHOSPHOSERINE | 4 |
| XOO | 4-{2-[({4-[(2P)-2-(2-aminopyridin-3-yl)-5-phenyl-3H-imidazo[4,5-b]pyridin-3-yl]phenyl}methyl)amino]ethyl}-2-hydroxybenzaldehyde | 4 |